Results 91 to 100 of about 34,380 (305)
AT 2019aalc: A Bowen Fluorescence Flare with a Precursor Flare in an Active Galactic Nucleus
The Astrophysical JournalAT 2019aalc is a peculiar sequence of highly variable emission events observed towards the nucleus of the broad-line active galactic nucleus (AGN) SDSS J152416.66+045119.0.Marzena Śniegowska, Benny Trakhtenbrot, Lydia Makrygianni, Iair Arcavi, Claudio Ricci, Sara Faris, Biswaraj Palit, D. Andrew Howell, Megan Newsome, Joseph Farah, Curtis McCully, Estefania Padilla-Gonzalez, Giacomo Terreran +12 moredoaj +1 more sourceGRB 050713A: High Energy Observations of the GRB Prompt and Afterglow
Emission
, 2006 Swift discovered GRB 050713A and slewed promptly to begin observing with its
narrow field instruments 72.6 seconds after the burst onset, while the prompt
gamma-ray emission was still detectable in the BAT.A. D. Falcone, A. P. Beardmore, A. Stamerra, Aptekar R. L., Barthelmy S., Burrows D. N., C. Pagani, D. C. Morris, D. N. Burrows, H. Krimm, J. Reeves, M. Garczarczyk, M. Gaug, M. Teshima, Mirzoyan R., N. Galante, N. Gehrels, O. Godet, Piro L., S. Golenetskii, S. Mizobuchi, V. Pal’shin +21 morecore +3 more sourcesEffect of Time to Start of Biologic Therapy on Treatment Response in Childhood Arthritis: Results From the UCAN CAN‐DU Cohort
Arthritis &Rheumatology, EarlyView.Objective
To estimate the effect of time from symptom onset to start of biologic treatment on achieving inactive arthritis within six months in a cohort of patients with juvenile idiopathic arthritis (JIA). Methods
The international UCAN CAN‐DU study prospectively enrolled patients with JIA across Canada and the Netherlands.Jelleke B. de Jonge, Sytze de Roock, Dieneke Schonenberg‐Meinema, J. Merlijn van den Berg, Deborah A. Marshall, Sebastiaan J. Vastert, Rae S. M. Yeung, Joost F. Swart, Susanne M. Benseler, on behalf of the UCAN CAN‐DU and UCAN CURE consortia, Adam Huber, Bianca Lang, Chelsea DeCoste, Elizabeth Stringer, Suzanne Ramsey, Alan Rosenberg, Kate Neufeld, Mehul Jariwala, Tristan Kerr, Alexander Mosoiu, Alisa Rachlis, Amy Xu, Arthur Cheng, Brenleigh Jebb, Brian Feldman, Bruno Pereira, Deborah Levy, Dilan Dissanayake, Elizaveta Limenis, Evelyn Rozenblyum, Harper Cheng, Jennifer Ji Young Lee, Lynn Spiegel, Rayfel Schneider, Ronald Laxer, Ruud Verstegen, Shirley Tse, Trang Duong, Andrea Human, David Cabral, Herman Tam, Jaime Guzman, Kim Morishita, Kristin Houghton, Lori Tucker, Mercedes Chan, Ross Petty, Tommy Gerschman, Annet van Royen‐Kerkhof, Berent Prakken, Erika Van Nieuwenhove, Marc Jansen, Nico Wulffraat, Ciarán Duffy, Nadia Luca, Roman Jurencak, Tala El Tal, Claire LeBlanc, Gaëlle Chédeville, Piya Lahiry, Rosie Scuccimarri, Sarah Campillo, Clare Hutchinson, Daniah Basodan, Dax G. Rumsey, Hon Yan Ng, Jeanine McColl, Lillian Lim, Tara McGrath, Danielle Brinkman, Petra Hissink Muller, Elizabeth Legger, Wineke Armbrust, Ellen Schatorje, Esther Hoppenreijs, Elodie Boudes, Gillian Currie, Heinrike Schmeling, Muhammed Dhalla, Nicole Johnson, Paivi Miettunen, Ravneet Sran, Rebeka Stevenson, Erkan Demirkaya, Jonathan Park, Roberta Berard, Giske Biesbroek, Mariken Gruppen, Gordon Soon, Joseph Cafazzo, Liane Heale, Michelle Batthish, Tania Cellucci, Lily Lim, Maarten IJzerman, Marinka Twilt, Marleen Verkaaik, Philomine van Pelt, Sylvia Kamphuis, Michelle Kip, Nickolas Blanchette, Paul Dancey, Regina de Geus +102 morewiley +1 more sourceUnusual Flaring Activity in the Blazar PKS 1424-418 during 2008-2011
, 2014 Context. Blazars are a subset of active galactic nuclei (AGN) with jets that
are oriented along our line of sight. Variability and spectral energy
distribution (SED) studies are crucial tools for understanding the physical
processes responsible for ...Angelakis, E., Bastieri, D, Blanchard, J. M., Buson, S., Ciprini, S., Cutini, S., D'Ammando, F., Desiante, R., Donato, D., Dutka, M., Edwards, P. G., Finke, J., Fuhrmann, L., Gurwell, M. A., Hauser, M., Kadler, M., Larsson, S., Longo, F., Lovell, J. E. J., Müller, C., Ojha, R., Stevens, J., Thompson, D. J., Wagner, S., Wehrle, A. E., Zensus, J. A., Zook, A. +26 morecore +1 more sourceTofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient‐Reported Outcomes in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Withdrawal Trial
Arthritis &Rheumatology, EarlyView.Objective
Juvenile idiopathic arthritis (JIA) is associated with impaired overall health‐related quality of life (HRQoL). We evaluated the impact of tofacitinib on patient‐reported outcomes (PROs) in patients with JIA. Methods
This was a post hoc analysis of a phase 3, randomized, double‐blind, placebo‐controlled withdrawal trial (NCT02592434) in ...Hermine I. Brunner, Ekaterina Alexeeva, Marcia Bandeira, Ruy Carrasco, Jeffrey Chaitow, Peter Chiraseveenuprapund, Tracy V. Ting, Muferet Erguven, Beth Gottlieb, Sheila Knupp Oliveira, Pooja N. Patel, Seza Ozen, Claudia Saad Magalhaes, Inmaculada Calvo Penadés, David Gruben, Rebecca Germino, Holly B. Posner, Lori Stockert, Alberto Martini, Daniel J. Lovell, Nicolino Ruperto, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and Pediatric Rheumatology Collaborative Study Group (PRCSG) +21 morewiley +1 more sourceIs OJ 287 a Single Supermassive Black Hole?
Universe, 2020 Light curves for more than century optical photometric observations of the blazar OJ 287 reveals strong flares with a quasi-period of about 12 years. For a long time, this period has been interpreted by processes in a binary black hole system. We propose Marina S. Butuzova, Alexander B. Pushkarev +1 moredoaj +1 more sourceX-Ray Flares and Oscillations from the Black Hole Candidate X-Ray
Transient XTE J1650-500 at Low Luminosity
, 2003 We report on X-ray observations made with the Rossi X-ray Timing Explorer of
the black hole candidate (BHC) transient XTE J1650-500 at the end of its first,
and currently only, outburst.Augusteijn T., Baganoff F. K., Blandford R. D., Bradt H. V., Castro-Tirado A. J., Castro-Tirado A. J., Chevalier C., di Matteo T., Eckart A., Emrah Kalemci, Garcia M. R., Groot P., Hameury J., John A. Tomsick, Markwardt C., Osaki Y., Philip Kaaret, Remillard R., Revnivtsev M., Sanchez-Fernandez C., Stephane Corbel, Tomsick J. A., Tomsick J. A., Wijnands R. +23 morecore +1 more sourceRisk factors for relapse in ANCA‐associated vasculitis among patients with relapse after induction of remission with rituximab
Arthritis &Rheumatology, Accepted Article.Objective
To determine risk factors for relapse of ANCA‐associated vasculitis (AAV) after re‐induction of remission with rituximab and discontinuation of maintenance therapy. Methods
This is a post‐hoc analysis of the RITAZAREM clinical trial. Patients 15 years or older with AAV and a positive test for anti‐proteinase‐3 (PR3‐) or anti‐myeloperoxidase ...Ellen Romich, Joshua F. Baker, Thomas R. Riley IV, Ian Green, Rennie L. Rhee, Carol A. McAlear, Ulrich Specks, Rona M. Smith, David R. Jayne, Peter A. Merkel, for the RITAZAREM Investigators +10 morewiley +1 more source